May 29, 2024
The University of Cincinnati's Ann Romaker was featured in a Prevention article providing recommendations on the best earplugs for sleeping.
July 9, 2024
The University of Cincinnati's Charles Hattemer spoke with the New York Times about how stress can trigger chronic diseases.
February 22, 2021
Shaina Horner, a clinical researcher in the Division of Infectious Diseases used her connections in the local Latinx community to help recruit a diverse population for the Moderna COVID-19 vaccine trial.
July 20, 2022
Yahoo News featured the University of Cincinnati's Jennifer Molano in an article about ways to boost your immunity during the BA.5 surge of COVID-19 cases.
November 7, 2023
The University of Cincinnati Cancer Center’s Vladimir Bogdanov found a new drug developed in his lab was effective at preventing pancreatic cancer growth and spread when combined with chemotherapy in lab tests.
August 30, 2022
The Guardian featured University of Cincinnati researcher Erica Birkley in an article on the effect of Americans halting COVID precautions on vulnerable populations.
October 20, 2022
New research out of the University of Cincinnati shows that a course of a hepatitis B vaccine provides complete protection for people with HIV. The UC research shows that a three-dose course of the hepatitis B vaccine HEPLISAV-B provides complete protection for people living with HIV who have never been vaccinated against or exposed to the hepatitis B virus (HBV).
July 15, 2024
Dialysis patients using a more traditional home hemodialysis procedure have lower incidence of cardiovascular disease than patients using a less invasive peritoneal dialysis at home, a University of Cincinnati researcher finds.
March 16, 2023
The University of Cincinnati's Bingfang Yan's research team has received a $2.5 million National Institutes of Health grant to answer the question of how FDA-approved COVID-19 therapeutics can work together to create more effective and safe treatments for patients.
March 22, 2023
Local 12 highlighted the University of Cincinnati's Bingfang Yan, who recently received a a $2.5 million National Institutes of Health grant to study how COVID-19 therapeutics can work together to create more effective and safe treatments for patients.